Fundz

Allotex, Inc. reported raising $16.7 Million in an initial SEC Form D filing, from an offering of $16.7 Million

PRIVATEMar 02, 2018

Amount Raised

$16.7 Million

$16.7 Million sold, per SEC Form D (first sale Mar 2, 2018)

Round Type

Venture

BostonBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Allotex that raised within 45 days of this round, from Fundz verified event records.

  • Tusker Medical, Inc. raised $7M on April 16, 2018.
  • EIP Pharma, Inc. raised $20M on April 13, 2018.
  • Evecxia raised $7.4M on April 13, 2018.
  • Intrommune Therapeutics, Inc. raised an undisclosed amount on April 12, 2018.
  • CESCA THERAPEUTICS INC. raised $817K (Seed) on April 12, 2018.
  • ImmersiveTouch raised $900K (Seed) on April 12, 2018.

Who to call at Allotex, and when

A new round usually means Allotex is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Allotex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Allotex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Allotex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Allotex

Location

27-43 WORMWOOD ST.

Boston, Massachusetts, United States

About

Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia, hyperopia, and myopia. The therapy is accomplished through tissue addition technology that uses precisely-shaped human corneal allografts to create what is essentially a permanent, living contact lens or lens insert.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Allotex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Allotex's next move

See what Strategic adds

Allotex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.